BECHERINI, CARLOTTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.192
AS - Asia 3.053
EU - Europa 2.677
SA - Sud America 317
AF - Africa 73
OC - Oceania 44
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.129
RU - Federazione Russa 1.129
CN - Cina 934
SG - Singapore 844
IT - Italia 714
HK - Hong Kong 428
KR - Corea 266
BR - Brasile 252
VN - Vietnam 223
IE - Irlanda 182
SE - Svezia 135
FR - Francia 132
DE - Germania 122
IN - India 92
GB - Regno Unito 63
FI - Finlandia 62
BD - Bangladesh 56
PL - Polonia 50
JO - Giordania 49
AU - Australia 42
ID - Indonesia 41
CA - Canada 33
AR - Argentina 31
JP - Giappone 25
NL - Olanda 18
IQ - Iraq 17
MX - Messico 16
NG - Nigeria 15
EC - Ecuador 13
UA - Ucraina 13
ES - Italia 12
MA - Marocco 12
TR - Turchia 9
ZA - Sudafrica 9
CH - Svizzera 8
PK - Pakistan 8
VE - Venezuela 8
CI - Costa d'Avorio 7
EG - Egitto 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
SA - Arabia Saudita 6
IL - Israele 5
KE - Kenya 5
SC - Seychelles 5
TN - Tunisia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BJ - Benin 4
CO - Colombia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
KZ - Kazakistan 4
PE - Perù 4
AL - Albania 3
CL - Cile 3
CR - Costa Rica 3
CY - Cipro 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
TJ - Tagikistan 2
AQ - Antartide 1
BW - Botswana 1
CG - Congo 1
EE - Estonia 1
GE - Georgia 1
GL - Groenlandia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
KY - Cayman, isole 1
LV - Lettonia 1
MT - Malta 1
MY - Malesia 1
PR - Porto Rico 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TL - Timor Orientale 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 10.357
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.051
Singapore 631
Ashburn 609
Hong Kong 380
Hefei 312
Seoul 266
Fairfield 207
San Jose 205
Chandler 185
Dublin 181
Seattle 125
Milan 120
Woodbridge 117
Beijing 113
Cambridge 91
Los Angeles 86
Houston 84
Wilmington 82
Ho Chi Minh City 80
Munich 76
Buffalo 65
New York 53
Kent 52
Lauterbourg 50
Florence 48
Paris 47
The Dalles 47
Altamura 46
Rome 46
Dearborn 45
Warsaw 44
Lawrence 43
Moscow 43
Hanoi 42
Shanghai 41
Council Bluffs 40
Melbourne 38
Ann Arbor 37
Mumbai 32
Princeton 31
Boston 29
Dallas 26
Helsinki 26
Naples 26
São Paulo 26
Jakarta 22
London 22
Bengaluru 21
Turku 21
Frankfurt am Main 20
San Diego 20
Tokyo 20
Boardman 17
Chicago 17
Stockholm 14
Guangzhou 13
Clifton 12
Denver 11
Abuja 10
Brooklyn 10
Da Nang 10
Lappeenranta 10
Medford 10
Miano 10
Pune 10
Baghdad 9
Orem 9
Rio de Janeiro 9
Yubileyny 9
Chennai 8
Haiphong 8
Montreal 8
Porto Alegre 8
Quito 8
Redondo Beach 8
Shenzhen 8
Turin 8
West Jordan 8
Zhengzhou 8
Abidjan 7
Bari 7
Bologna 7
Hải Dương 7
Salt Lake City 7
Tianjin 7
Brescia 6
Brussels 6
Malang 6
Manchester 6
Mexico City 6
Modena 6
Palermo 6
Phoenix 6
Poplar 6
Ribeirão Preto 6
San Francisco 6
Somma Vesuviana 6
Toronto 6
Buenos Aires 5
Campinas 5
Totale 6.570
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 247
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 245
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 237
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 235
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer 227
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 222
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 218
Influence of age and subtype in outcome of operable liposarcoma 218
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 216
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 214
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 207
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 206
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 206
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 201
Radiotherapy in the age of cancer immunology: Current concepts and future developments 195
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 194
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 188
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 186
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 186
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 181
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 178
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 177
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 176
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 175
Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria 173
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 171
Association of Breast Cancer Irradiation with Cardiac Toxic Effects: A Narrative Review 169
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 168
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 168
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 167
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 166
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 166
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 165
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 165
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 164
The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study 160
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 159
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 158
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 155
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 153
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 152
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 148
Partial breast irradiation for ductal carcinoma in situ: The Goldilocks principle? 148
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 145
Radiobiology of stereotactic radiotherapy 140
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 139
The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation 139
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review 139
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial 138
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques 137
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 132
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 131
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 130
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 123
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 117
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 112
Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network 108
Radiation therapy on the axilla after neoadjuvant chemotherapy 99
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures 96
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 94
Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future 93
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 85
null 57
Multimodal De-Escalation Strategies in Early Breast Cancer 50
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials 17
Totale 10.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022183 6 8 6 12 5 11 2 23 12 7 27 64
2022/2023867 52 153 49 24 67 153 103 92 120 4 27 23
2023/2024606 28 46 61 36 45 83 43 141 22 28 52 21
2024/20253.533 100 306 155 523 919 471 74 277 177 108 156 267
2025/20264.228 465 586 550 383 448 131 500 205 213 245 141 361
2026/202714 14 0 0 0 0 0 0 0 0 0 0 0
Totale 10.431